Caricamento...

Clinical data from the real world: efficacy of Crizotinib in Chinese patients with advanced ALK-rearranged non-small cell lung cancer and brain metastases

Brain metastasis in non small cell lung cancer (NSCLC) patients is often considered as a terminal stage of advanced disease. Crizotinib is a small-molecule tyrosine kinase inhibitor (TKI) for ALK-rearranged NSCLC patients. Herein, we conducted a retrospective study to explore how Crizotinib affects...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Xing, Puyuan, Wang, Shouzheng, Hao, Xuezhi, Zhang, Tongtong, Li, Junling
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2016
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5356690/
https://ncbi.nlm.nih.gov/pubmed/27835868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13179
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !